Evolent Health, Inc. (EVH)

NYSE: EVH · IEX Real-Time Price · USD
32.73
+0.60 (1.87%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Total Valuation

Evolent Health has a market cap or net worth of $3.73 billion. The enterprise value is $4.16 billion.

Market Cap 3.73B
Enterprise Value 4.16B

Important Dates

The next estimated earnings date is Wednesday, May 1, 2024, after market close.

Earnings Date May 1, 2024
Ex-Dividend Date n/a

Share Statistics

Evolent Health has 115.43 million shares outstanding. The number of shares has increased by 18.73% in one year.

Shares Outstanding 115.43M
Shares Change (YoY) +18.73%
Shares Change (QoQ) +1.18%
Owned by Insiders (%) 4.17%
Owned by Institutions (%) 112.02%
Float 109.13M

Valuation Ratios

PE Ratio n/a
Forward PE 26.26
PS Ratio 1.90
Forward PS 1.49
PB Ratio 3.49
P/FCF Ratio 32.73
PEG Ratio -1.37
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.12
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 36.58

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.60.

Current Ratio 1.01
Quick Ratio 0.97
Debt / Equity 0.60
Debt / EBITDA n/a
Debt / FCF 5.66
Interest Coverage -2.73

Financial Efficiency

Return on equity (ROE) is -13.00% and return on invested capital (ROIC) is -3.11%.

Return on Equity (ROE) -13.00%
Return on Assets (ROA) -5.40%
Return on Capital (ROIC) -3.11%
Revenue Per Employee $417,850
Profits Per Employee -$30,268
Employee Count 4,700
Asset Turnover 0.74
Inventory Turnover n/a

Taxes

Income Tax -89.37M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +4.20% in the last 52 weeks. The beta is 1.54, so Evolent Health's price volatility has been higher than the market average.

Beta (1Y) 1.54
52-Week Price Change +4.20%
50-Day Moving Average 31.81
200-Day Moving Average 29.31
Relative Strength Index (RSI) 50.75
Average Volume (30 Days) 999,037

Short Selling Information

The latest short interest is 11.24 million, so 9.74% of the outstanding shares have been sold short.

Short Interest 11.24M
Short Previous Month 11.19M
Short % of Shares Out 9.74%
Short % of Float 10.30%
Short Ratio (days to cover) 9.94

Income Statement

In the last 12 months, Evolent Health had revenue of $1.96 billion and -$142.26 million in losses. Loss per share was -$1.28.

Revenue 1.96B
Gross Profit 460.47M
Operating Income -53.23M
Pretax Income -202.41M
Net Income -142.26M
EBITDA -24.79M
EBIT -148.20M
Loss Per Share -$1.28
Full Income Statement

Balance Sheet

The company has $206.59 million in cash and $644.80 million in debt, giving a net cash position of -$438.20 million or -$3.80 per share.

Cash & Cash Equivalents 206.59M
Total Debt 644.80M
Net Cash -438.20M
Net Cash Per Share -$3.80
Equity / Book Value 1.07B
Book Value Per Share 9.25
Working Capital 9.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $142.58 million and capital expenditures -$28.75 million, giving a free cash flow of $113.84 million.

Operating Cash Flow 142.58M
Capital Expenditures -28.75M
Free Cash Flow 113.84M
FCF Per Share $1.02
Full Cash Flow Statement

Margins

Gross margin is 23.45%, with operating and profit margins of -2.71% and -7.24%.

Gross Margin 23.45%
Operating Margin -2.71%
Pretax Margin -10.31%
Profit Margin -7.24%
EBITDA Margin -1.26%
EBIT Margin -7.55%
FCF Margin 5.80%

Dividends & Yields

Evolent Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.73%
Shareholder Yield -18.73%
Earnings Yield -3.82%
FCF Yield 3.06%
Dividend Details

Analyst Forecast

The average price target for Evolent Health is $42.63, which is 30.25% higher than the current price. The consensus rating is "Buy".

Price Target $42.63
Price Target Difference 30.25%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 13.02%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Evolent Health has an Altman Z-Score of 1.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.74
Piotroski F-Score 3